Scilex Holding (SCLX) Invested Capital (2021 - 2026)
Scilex Holding (SCLX) posted quarterly Invested Capital of $80.8 million for Q1 2026, up 104.81% year-over-year from $39.4 million in Q1 2025, and down 2.98% quarter-over-quarter from $83.3 million in Q4 2025.
Scilex Holding (SCLX) Invested Capital (2021 - 2026) Analysis & Trends
Scilex Holding's Invested Capital history runs 5 years deep, the most recent figure standing at $80.8 million for Q1 2026.
- In Q1 2026, Invested Capital rose 104.81% year-over-year to $80.8 million; the TTM figure through Mar 2026 stood at $249.6 million (up 6.51% YoY), while the FY2025 annual figure was $83.3 million, up 138.74% from the prior year.
- Invested Capital for Q1 2026 stood at $80.8 million, down from $83.3 million in the prior quarter.
- The five-year high for Invested Capital was $115.2 million in Q3 2023, with the low at $15.9 million in Q2 2023.
- The 4-year median for Invested Capital is $78.1 million (2024), against an average of $68.0 million.
- Peak annual rise in Invested Capital reached 373.55% in 2024, while the deepest fall reached 67.84% in 2024.
- Scilex Holding's Invested Capital stood at $108.4 million in 2023, then slumped by 67.84% to $34.9 million in 2024, then soared by 138.74% to $83.3 million in 2025, then fell by 2.98% to $80.8 million in 2026.
- Business Quant data shows SCLX's Invested Capital at $80.8 million in Q1 2026, $83.3 million in Q4 2025, and $45.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 11.69 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 8.34 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.83 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 9.59 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 32.24 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 5.45 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 2.41 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 2.70 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -7.25 Bn |
| 10 | Scilex Holding | 39.22 Mn | -73.57 Mn | 3.97 Mn | 80.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.78 Mn |
| Dec 31, 2025 | 83.26 Mn |
| Sep 30, 2025 | 45.67 Mn |
| Jun 30, 2025 | 39.87 Mn |
| Mar 31, 2025 | 39.44 Mn |
| Dec 31, 2024 | 34.88 Mn |
| Sep 30, 2024 | 84.64 Mn |
| Jun 30, 2024 | 75.37 Mn |
| Mar 31, 2024 | 92.92 Mn |
| Dec 31, 2023 | 108.43 Mn |
| Sep 30, 2023 | 115.22 Mn |
| Jun 30, 2023 | 15.92 Mn |
| Dec 31, 2021 | 37.95 Mn |